Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Welcome aboard mfs.... the ADXS science is what makes me worry free no matter what the share price is....
We are almost there, just a few years till ADSS makes go to market with $100+ IMHO... excluding the short term appreciation of AT-014 and EU submission...
Link not working for me...
Also, ADXS Board didn't exist then right?
As I was following ADXS, DOC hand picked the scientific board..... and they backstabbed DOC....
Greedy or not, DOCs leaving ADXS caused ADXS drop to the 52 week low
I think I first found out about ADXS late 2024 / early 2015....
When I waited and waited and waited for it to fall down but it kept rising and rising rising all the way from like $2 to $30.... and that's when the stupid me was like enough is enough and invest in ADXS already.....
Dumbass move looking back now lol
If there is one thing ADXS Management is good at, it's the science.....
Historically, as I know, every single submission made by ADXS has been approved no questions asked so far....
So I say the probability of getting EU approval after submission is 99.9999999999999999%
Looks like ADXS gave you a penny more than you asked for.... party time?
So after BMYs Opdivo failed at a lung cancer trail, and MRKs Keytruda gave good lung trail results...
I am of the opinion that Keytruda is the top miracle drug in market right now...
What happens when you mix, top miracle drug (Keytruda) with top miracle platform (ADXS LM)?
Good observation, thanks for the post.
Agreed, no volume
ADXS Volume and price up accelerating up!!!
ADXS breaking up with some good volume, let's see if this continues!!!
Does anyone know if EU Marketing Plan is required for EU Submission? Did KITE have to do it?
I'm new to KITE, and would appreciate this info, thanks
Good to know thanks, did they give a reason why the study is delayed?
Joe,
This seems like an old article given a new date? Third quarter is about to end, so where is the study results?
"We expect to the program will be in full swing by the end of the month and hope to have it completed by during the second quarter of 2017, and in the hands of patients shortly thereafter.”
Why was the presentation canceled?
I am glad to see your posts again Terry, it's been a long time...
People here are tired from the long wait and a few people undermining the incredible LM technology and underselling cheap ADXS buyout prices...,
Always good to hear how far back this effort has come from, a long history in the making, and it's just a matter of "when" ADXS platform hits market not "if"
That's the negative... no CEO to bust employees' chops for work progress... they slow down
James, do you have the link for ADXS phase 3 trail? Curious if they opened any more testing sites? Especially overseas testing sites? Like Latin America (partnership with Stendhal)... and stuff
Can someone please help with KITE's info:
Was marketing plan required with EU submission of KITE? If so, did KITE partner with anyone for EU market or does KITE have its own EU marketing plan and resources?
I did a little research, couldn't find any direct wording on EU marking by KITE...
However, KITE does have its own EU marketing department, and they have a job open for Director of EU marketing per link below:
https://careers.jobscore.com/careers/kitepharma/jobs/director-marketing-europe-bndc2OEeir56S1dG1ZS6tF
AZN has not pulled out yet, not official yet.
Same Institutions pulling out of ADXS are pulling out of other stocks as well...
Let's take worst case institutional example:
Broadfin closed out its position in ADXS...
Well you know what, they also closed out its position on PETX...
so institutions pulling out is their issues and plannings, nothing to do with the company specifically....
I didn't see any news of KITE partnering with anyone for EU Submission: link below is press release for EU submission by KITE, and no mention of partnership
http://ir.kitepharma.com/releasedetail.cfm?releaseid=1035076
And I would say that ADXS is a real company with real science (HPV phase 2 at 38% best stats, 100% complete response on An*l cancer, and 100% complete response in throats cancer)...
Doesn't get better than 100% right?
So KITE got bought a month after it made the EU submission....
ADXS is getting ready to made the EU submission..... Hmmmmm...
Lol sandman, you in PETX as well? I own PETX also
There is a difference between business savvy CEO and technically savvy CEO...
I personally don't like technically savvy CEOs cuz they tend to be bad at making deals....
For example: TEVA CEO was technically savvy, and got TEVA in $40 billion debt by buying now worthless generics from AMGEN....
Look at TEVA's chart crashing
I like how some new ADXS trails are planned to start with Midway, just imagine the number of ADXS phase 3 trails a year from now!!! At least 4 phase 3 trails by 2018!!!!!!!!!
Saves time and money!
ADXS Dual AN*L (With RTOG): phase 3 start 2H 2017
ADXS Dual Combo with BMY: phase 3 start 2H 2017
ADXS-HER2 Pediatric Osteosarcoma: phase 2 start in 2H 2017
Due to this, biotech sector should be green today... let's see if ADXS follows the sector as green today?
Good info, thanks
I lost the link from the morning, but here's another one (Nasdaq shows much lower percentage by the way, kinda surprised)
https://www.gurufocus.com/ownership/NAS:ADXS
I am sorry to hear that, a big loss indeed.
I am new to HEMP, I like HEMP's current progress, but I don't like its financial condition and continuous dilution.... plus that SEC case going on....
So I'm double minded at the moment. Comments are welcomed, what do you guys think?
ADXS Ownership:
% Owned by Insiders 7.87%
% Owned by Institutions 61.10%
% sold by shorties which needs to be covered is approximately 25%
% of ADXS shares trading daily 0.7% (calculated with shorted shares included)
Based on this picture.... only way is up
Thanks for easy clarification.
Can someone please help me with following explanation of OWCP 10Q:
"During the period, the engagement of the Subsidiary’s CEO was terminated and the CFO resigned. "
Does above mean OWCP CEO and CFO were just replaced in past 6 months?
"Received an IRB approval for a Phase I, double blind, randomized, placebo controlled, multiple escalating dose study to determine the safety, tolerability and pharmacokinetic profile of medical grade cannabis in healthy volunteers." This is regarding psoriasis
Does above mean, that phase 2 and 3 will follow phase 1? If so, psoriasis can take 3-5 years to hit market or even more...
When I asked the question about 10Q, people on this board replied that there was no dilution in the latest 10Q... is that correct?
"Its not beyond reason that pps could reach $20-30 by year end"
Translation:
It is not beyond reason for ADXS to catch up to low end of its "FAIR VALUE" of $20-$30 by year end
Anyone who truly followed ADXS for atleast a year would agree with this
What do you guys think of OWCP 146 million outstanding shares? Isn't that a lot?
That's huge purchase compared to daily volume, thanks for the post
Mono will always be good... ADXS science works...
The question does Combo work? In AZN's case, combo didn't help cuz AZN's stuff sucked....
In case of MRK, Keytruda has proven itself and made it to market, so hopefully the combo would deliver better results than mono....
What do you guys think of OWCP 10Q? Spend a lot of money this quarter and diluted?
Not trying to be negative, I just want to under your opinion on OWCP financial condition and if there will be more dilution?